Akero Therapeutics Inc (AKRO)
31.20
+0.56
(+1.84%)
USD |
NASDAQ |
Nov 21, 16:00
31.22
+0.02
(+0.06%)
After-Hours: 20:00
Akero Therapeutics Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Madrigal Pharmaceuticals Inc | 0.1507 |
| 89bio Inc | -- |
| NovaBay Pharmaceuticals Inc | 0.0476 |
| Palatin Technologies Inc | -- |
| iBio Inc | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 817.55M |
| Total Liabilities (Quarterly) | 79.22M |
| Shareholders Equity (Quarterly) | 738.32M |